fda compounding semaglutide news october 2025 September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines Congress Introduces SAFE Drugs Act

District Court for the Western District of Louisiana, is the first to allege the medication can cause gastrointestinal injuries, NBC News reported

Tirzepatide is an FDA- and EMA-approved dual GIP/GLP-1 receptor agonist with multiple completed Phase 3 trials behind it

Each has distinct properties and applications

Different upper airway microbiome and their functional genes associated with asthma in young adults and elderly individuals

While phentermine is a generic drug, it is also available under the brand names Adipex-P, Lomaira, Fastin, and others

Regulatory & Medical Community Viewpoint (2025) The leading dermatology and pharmacology reviews caution against parenteral (IV/IM) glutathione for cosmetic skin-lightening citing lack of robust evidence and significant safety concerns